Reckitt Benckiser Group Q4 Earnings Call Highlights

Core Insights - The company reported strong financial performance in 2025, with growth driven by emerging markets and margin expansion supported by the Fuel for Growth program [4][5] - Core Reckitt's net revenue grew by 5.2% in 2025, surpassing the company's guidance of above 4% [3] - The company aims for 4%-5% growth in 2026, primarily led by emerging markets, while acknowledging challenges in Europe and seasonal OTC categories [5][16] Financial Performance - Adjusted operating profit increased by 5.3% at constant currency, with Core Reckitt's operating margin expanding by 90 basis points to 26.7% [1] - Group net revenue rose by 5%, with Mead Johnson Nutrition contributing 3.8% growth [3] - Free cash flow was £1.7 billion, with a conversion rate of 71% [6][7] Capital Returns and Leverage - The company returned £2.3 billion to shareholders, including £900 million in buybacks and a £1.6 billion special dividend [6][7] - Net debt to adjusted EBITDA ended the year at 1.6x, with expectations to peak near 2.5x by mid-2026 [8] - A 5% increase in the full-year dividend was proposed, aligning with the company's sustainable dividend growth strategy [9] Regional Performance - Emerging markets showed broad-based growth, with Core Reckitt growth of 14.6% and volumes up 6.7%, particularly in China and India [2][10] - Europe experienced a decline of 1.4% due to slowing category growth and increased promotional activity, although adjusted operating margin rose to 31.4% [11] - North America was broadly flat, with a 0.2% increase in like-for-like net revenue [12] Strategic Initiatives - The Fuel for Growth program is central to investment capacity and margin performance, with fixed costs improving to 19.4% of net revenue in 2025 [12] - Capital expenditure increased to £592 million, focusing on localization, automation, and digitization to enhance supply chain resilience [13] - Innovation remains a priority, with new product launches planned, including Mucinex 12 Hour Cold and Fever [14] Category Performance - Self-care net revenue increased by 3%, driven by high single-digit growth in non-seasonal self-care products [15] - Germ protection grew by 8.4%, led by strong performance from Dettol in emerging markets [15] - Intimate Wellness was the fastest-growing category, up 12.5% like-for-like, with significant growth in brands like Durex and Veet [15]